Navigation Links
University of Maryland chemist receives Astellas Award for blindness prevention research
Date:12/10/2009

WASHINGTON, Dec. 10, 2009 Fredrick Khachik, Ph.D., a senior research scientist in the Department of Chemistry and Biochemistry at the University of Maryland, College Park, has been chosen to receive a 2009 Astellas USA Foundation Award. The award, administered by the American Chemical Society, is given to individuals who have made significant scientific research contributions that improve public health through their work in the chemical and related sciences.

The award includes a $30,000 grant to support his continuing research efforts.

Khachik's research focused on dietary compounds called carotenoids found in fruits and vegetables. These compounds accumulate in the retina and can help prevent age-related macular degeneration (AMD), which causes a loss of central vision. Khachik developed a process to isolate and purify two of these carotenoids, lutein and zeaxanthin, from marigold flowers and plants. Prior to this innovation, the biological properties of these two compounds could not be investigated in clinical trials. The National Eye Institute is currently conducting a multi-center, randomized clinical trial known as: "The Age-Related Eye Disease Study 2 (AREDS2)" to assess the effects of oral supplementation of lutein and zeaxanthin on the progression to AMD. (http://www.areds2.org).

Khachik received his B.S. degree from Pars College in Iran and earned his M.S. and Ph.D. degrees in organic chemistry from the University of Manchester Institute of Science and Technology in the United Kingdom. He has been affiliated with the University of Maryland since 1997.


'/>"/>

Contact: Doug Dollemore
d_dollemore@acs.org
202-872-4091
American Chemical Society
Source:Eurekalert  

Page: 1

Related medicine news :

1. University of Alberta researchers develop drug interface to save lives
2. University of Utah Announces New Studies on the Benefits of Treadmill Desks
3. New License Agreement with University of Colorado Gives Viral Genetics, Inc., Right to Develop Cancer Therapies
4. Dont I know you? University of Toronto research sheds light on memorial retrieval
5. Topping Out Ceremony Marks Milestone in Construction of University Medical Center of Princeton at Plainsboro
6. Jenna Norwood to Present Award-Winning Documentary & Lecture at Harvard University
7. Champions Biotechnology signs exclusive agreement with Tel Aviv University for cancer drug
8. Trending Against the Norm: How One Top Scoring Ross University Medical Student is Choosing to Make a Difference in Internal Medicine
9. University HealthSystem Consortium and ECRI Institute(R) to Provide Enhanced Health Technology Assessment Services
10. Univalor and Cognitive Sensing Inc. to commercialize 4 University of Montreal discoveries
11. Quantros Licenses Adverse Event Identification Technology from University of Michigan
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
University of Maryland chemist receives Astellas Award for blindness prevention research
(Date:7/27/2017)... MD (PRWEB) , ... July 27, 2017 , ... ... Teams of entrepreneurs will compete to form startup companies around 117 breakthrough inventions ... Heart, Lung, and Blood Institute, and National Institute of Biomedical Imaging and Bioengineering), ...
(Date:7/27/2017)... ... July 27, 2017 , ... Cremations recently surpassed traditional burials ... Association, this trend is expected to continue with over 70% of Americans projected to ... demand for new innovations that enable families to celebrate the life of a lost ...
(Date:7/26/2017)... ... 2017 , ... An inventor from Salisbury, N.C., knows the difficulties involved with ... and dignified way to keep leeches in place during therapy," she said. "That’s why ... an effective way to keep a leech in place on the skin during therapy. ...
(Date:7/26/2017)... ... July 26, 2017 , ... Written By: ... a major advancement in drug therapy for patients living with relapsing and primary ... a novel B cell targeted therapy that has been proven to significantly reduce ...
(Date:7/26/2017)... , ... July 26, 2017 , ... ... Management Solutions as part of their continued efforts to provide innovative offerings to ... the best IT resources and build dynamic, high-performing teams to address healthcare IT’s ...
Breaking Medicine News(10 mins):
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/14/2017)... 14, 2017 Endo International plc (NASDAQ: ENDP ... 8, 2017.  Members of its senior management team will host a ... 8:30 a.m. ET. The dial-in number to access ... (678) 509-7598, and the passcode is 45397076. Please dial in 10 ... A replay of the call will be available ...
(Date:7/13/2017)...  New York City-based market research firm Kalorama Information notes ... of.  From new products to new costs, to the threat ... completed study, Potential Pipeline Disruptors . Among ... 1.  Age-Driven Growth - True Impact Moment Arriving   ... impact the growing population and, to a more extreme extent, ...
Breaking Medicine Technology: